首页> 外文期刊>Diabetes/metabolism research and reviews >Analysis of the HLA and non-HLA susceptibility loci in Japanese type 1 diabetes
【24h】

Analysis of the HLA and non-HLA susceptibility loci in Japanese type 1 diabetes

机译:日本1型糖尿病HLA和非HLA易感位点的分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: We previously reported the associations of human leukocyte antigen (HLA) (DRB1 and DQB1), INS, CTLA4, IL2RA, ERBB3 and CLEC16A with Japanese type 1 diabetes (T1D). In this study, we jointly analysed these loci in addition to IFIH1 and IL7R. Methods: A maximum of 790 T1D patients and 953 control subjects were analysed. HLA was determined by sequencing-based typing. Seven non-HLA single nucleotide polymorphisms were genotyped using TaqMan assay. Results: HLA DRB1*0405, DRB1*0901 and DRB1*0802-DQB1*0302 haplotypes were positively associated with T1D, while the DRB1*15 haplotypes were negatively associated. Non-HLA single nucleotide polymorphisms, INS, IL2RA, ERBB3, CLEC16A and IL7R were associated with T1D. By a prediction model using the HLA loci alone (HLA model) or the non-HLA loci alone (non-HLA model), it was revealed that the cumulative effect of the non-HLA model was much weaker than that of the HLA model (average increase in odds ratio: 1.17 versus 3.14). Furthermore, the area under the receiver operating characteristic curve of the non-HLA model was also much smaller than that of the HLA model (0.65 versus 0.81, p 10 -11). Finally, a patient-only analysis revealed the susceptible HLA haplotypes and the risk allele of INS to be negatively associated with slower onset of the disease. In addition, the DRB1*0901 haplotype and the risk alleles of ERBB3, CLEC16A and CTLA4 were positively associated with the co-occurrence of thyroid autoimmunity. Conclusions: Although several non-HLA susceptibility genes in Japanese were confirmed trans-racially and appear to contribute to the heterogeneity of the clinical phenotypes, the cumulative effect on the ability to predict the development of T1D was weak.
机译:背景:我们之前曾报道过人类白细胞抗原(HLA)(DRB1和DQB1),INS,CTLA4,IL2RA,ERBB3和CLEC16A与日本1型糖尿病(T1D)的关联。在这项研究中,我们共同分析了除IFIH1和IL7R之外的这些基因座。方法:最多分析790名T1D患者和953名对照受试者。 HLA通过基于测序的分型确定。使用TaqMan分析对7个非HLA单核苷酸多态性进行基因分型。结果:HLA DRB1 * 0405,DRB1 * 0901和DRB1 * 0802-DQB1 * 0302单倍型与T1D正相关,而DRB1 * 15单倍型负相关。非HLA单核苷酸多态性INS,IL2RA,ERBB3,CLEC16A和IL7R与T1D相关。通过使用单独的HLA基因座(HLA模型)或单独的非HLA基因座(non-HLA模型)的预测模型,发现非HLA模型的累积效应比HLA模型的累积效应弱得多(平均赔率比:1.17比3.14)。此外,非HLA模型的接收器工作特性曲线下的面积也远小于HLA模型的面积(0.65对0.81,p <10 -11)。最后,仅患者分析显示,易感的HLA单倍型和INS的风险等位基因与疾病的缓慢发作负相关。此外,DRB1 * 0901单倍型和ERBB3,CLEC16A和CTLA4的风险等位基因与甲状腺自身免疫的同时发生呈正相关。结论:尽管在日本人中有几个非HLA易感基因在种族间得到证实,并且似乎有助于临床表型的异质性,但对T1D发育预测能力的累积作用仍然很弱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号